Nationwide outcome registrations to improve quality of care in rectal surgery. An initiative of the European Society of Surgical Oncology

Journal of Surgical Oncology

Volumn 99, Issue 8, 2009, Pages 491-496

  Van Gijn, Willem ^a   Wouters, Michel W J M ^a   Peeters, Koen C M J ^a   Van De Velde, Cornelis J H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Audit; Colorectal cancer; Outcomes assessment; Rectal cancer; Review

Indexed keywords

BELGIUM; CANCER RECURRENCE; CANCER REGISTRY; CANCER SURGERY; COLORECTAL CANCER; DENMARK; EUROPE; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HUMAN; INTERNATIONAL COOPERATION; MEDICAL AUDIT; MEDICAL SOCIETY; MORTALITY; NETHERLANDS; NORWAY; ONCOLOGY; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PRIORITY JOURNAL; RECTUM CANCER; REVIEW; SURVIVAL RATE; SWEDEN; TREATMENT OUTCOME; UNITED KINGDOM; ORGANIZATION AND MANAGEMENT; RECTUM TUMOR; REGISTER; STATISTICS; TUMOR RECURRENCE;

EUROPE; HUMANS; INTERNATIONAL COOPERATION; MEDICAL AUDIT; NEOPLASM RECURRENCE, LOCAL; OUTCOME ASSESSMENT (HEALTH CARE); RECTAL NEOPLASMS; REGISTRIES; SURVIVAL RATE;

EID: 67049162128     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21203     Document Type: Review

References (44)

1. Chowdhury MM, Dagash H, Pierro A: A systematic review of the impact of volume of surgery and specialization on patient outcome. Br J Surg 2007;94:145-161. (Pubitemid 46340392)
2. Birkmeyer JD, Finlayson EV, Birkmeyer CM: Volume standards for high-risk surgical procedures: potential benefits of the Leapfrog initiative. Surgery 2001;130:415-422.
3. Wouters M: Outcome-based referral to improve quality of care in upper GI surgery. J Surg Oncol 2008;98:307-308.
4. The Leapfrog Group. http://www.leapfroggroup.org/ 2008. Ref Type: Electronic Citation.
5. The Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales. A policy framework for commissioning cancer services: a report by the Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales. http://www.dh.gov.uk/en/Publicationsandstatistics/ Publications/PublicationsPolicyAndGuidance/DH-4071083?Idc Service=GET- FILE&dID=17110&Rendition=Web. 1995. Ref Type: Electronic Citation.
6. Gatta G, Faivre J, Capocaccia R, et al.: Survival of colorectal cancer patients in Europe during the period 1978-1989. Eur J Cancer 1998;34:2176-2183.
7. MacFarlane JK, Ryall RD, Heald RJ: Mesorectal excision for rectal cancer. Lancet 1993;341:457-460. (Pubitemid 23054519)
8. Harnsberger JR, Vernava VM III, Longo WE: Radical abdominopelvic lymphadenectomy: historic perspective and current role in the surgical management of rectal cancer. Dis Colon Rectum 1994;37:73-87. (Pubitemid 24064274)
9. Heald RJ, Husband EM, Ryall RD: The mesorectum in rectal cancer surgery - the clue to pelvic recurrence? Br J Surg 1982; 69:613-616.
10. Heald RJ, Ryall RD: Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;1:1479-1482. (Pubitemid 16095660)
11. Norstein J, Langmark F: Results of rectal cancer treatment: a national experience. In: Soreide O, Norstein J, editors. Rectal cancer surgery: optimisation - standardisation - documentation. Oslo: Springer; 1997. pp 17-28.
12. Bjerkeset T, Edna TH: Rectal cancer: the influence of type of operation on local recurrence and survival. Eur J Surg 1996; 162:643-648. (Pubitemid 126439777)
13. Rein KA, Wiig JN, Saether OD, et al.: Local recurrence of rectal cancer. Tidsskr Nor Laegeforen 1987;107:2318-2320.
14. Soreide O, Norstein J: Local recurrence after operative treatment of rectal carcinoma: a strategy for change. J Am Coll Surg 1997;184:84-92. (Pubitemid 27010249)
15. Wiig JN, Carlsen E, Soreide O: Mesorectal excision for rectal cancer: a view from Europe. Semin Surg Oncol 1998;15:78-86. (Pubitemid 28387984)
16. Nagtegaal ID, Marijnen CA, Kranenbarg EK, et al.: Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 2002;26:350-357. (Pubitemid 34184459)
17. Wu ZY, Wan J, Li JH, et al.: Study of circumferential resection margin in patients with middle and lower rectal carcinoma.World J Gastroenterol 2007;13:3380-3383.
18. Wibe A, Moller B, Norstein J, et al.: A national strategic change in treatment policy for rectal cancer-implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002;45:857-866. (Pubitemid 34761463)
19. Frykholm GJ, Glimelius B, Pahlman L: Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 1993;36:564-572. (Pubitemid 23177416)
20. Stockholm Rectal Cancer Study Group. Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Cancer 1990;66:49-55.
21. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997; 336:980-987. (Pubitemid 27152783)
22. Martling A, Holm T, Johansson H, et al.: The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer 2001;92:896-902. (Pubitemid 32783078)
23. Pahlman L, Bohe M, Cedermark B, et al.: The Swedish rectal cancer registry. Br J Surg 2007;94:1285-1292. (Pubitemid 47584780)
24. Birgisson H, Talback M, Gunnarsson U, et al.: Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol 2005;31:845-853. (Pubitemid 41435253)
25. Harling H, Bulow S, Kronborg O, et al.: Survival of rectal cancer patients in Denmark during 1994-1999. Colorectal Dis 2004;6: 153-157.
26. Engeland A, Haldorsen T, Dickman PW, et al.: Relative survival of cancer patients - a comparison between Denmark and the other Nordic countries. Acta Oncol 1998;37:49-59. (Pubitemid 28179800)
27. Pahlman L, Dahlberg M, Glimelius B: Clinicopathological staging and management of colorectal cancer. Perioperative radiation therapy. World J Surg 1997;21:733-740.
28. The National Bowel Cancer Audit Programme. http://www. nbocap.org.uk 2008. Ref Type: Electronic Citation.
29. Tekkis PP, Smith JJ, Heriot AG, et al.: A national study on lymph node retrieval in resectional surgery for colorectal cancer. Dis Colon Rectum 2006;49:1673-1683. (Pubitemid 44800484)
30. Tilney HS, Tekkis PP, Sains PS, et al.: Factors affecting circumferential resection margin involvement after rectal cancer excision. Dis Colon Rectum 2007;50:29-36.
31. Report of The National Bowel Cancer Audit Programme "Quality Improvement & Open Reporting". http://www.nbocap.org.uk/ resources/reports/report2007.pdf 2008. Ref Type: Electronic Citation.
32. Penninckx F, Van EL, Michiels G, et al.: Survival of rectal cancer patients in Belgium 1997-1998 and the potential benefit of a national project. Acta Chir Belg 2006;106:149-157.
33. Penninckx F: Improving quality through knowledge translation at a national level. http://www.coldfusionwebhostings.be/PSK/ Upload/GENERAL// procare/presentaties/Knowledge-translation- ASCRS-june-2008.pdf Annual Meeting and Tripartite Meeting of the American Society of Colon & Rectal Surgeons, 7th June 2008, Boston, USA. 2008; Ref Type: Electronic Citation.
34. Dutch Surgical Colorectal Audit. http://www.dsca.nl 2008. Ref Type: Electronic Citation.
35. Kiesbeter, nl., http://www.kiesbeter.nl/ 2008. Ref Type: Electronic Citation.
36. Lied TR, Kazandjian VA: A Hawthorne strategy: implications for performance measurement and improvement. Clin Perform Qual Health Care 1998;6:201-204.
37. Rowell KS, Turrentine FE, Hutter MM, et al.: Use of national surgical quality improvement program data as a catalyst for quality improvement. J Am Coll Surg 2007;204:1293-1300. (Pubitemid 46819101)
38. Wouters MW, Wijnhoven BP, Karim-Kos HE, et al.: High-volume versus low-volume for esophageal resections for cancer: the essential role of case-mix adjustments based on clinical data. Ann Surg Oncol 2008;15:80-87.
39. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al.: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-646. (Pubitemid 34936565)
40. Kapiteijn E, Putter H, van d V: Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in the Netherlands. Br J Surg 2002;89:1142-1149. (Pubitemid 34989221)
41. Wibe A: Nationwide quality assurance of rectal cancer treatment. Colorectal congress, 28th November 2007, St. Gallen, Switzerland. 2007; Ref Type: Audiovisual Material.
42. Sauer R, Becker H, Hohenberger W, et al.: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740. (Pubitemid 39383208)
43. Peeters KC, Marijnen CA, Nagtegaal ID, et al.: The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007;246:693-701. (Pubitemid 350035641)
44. Darzi AW: NHS Next Stage Review final report. http://www.dh. gov.uk/en/publicationsandstatistics/publications/publicationspolicyandguidance/ DH-085825?IdcService=GET- FILE&dID=168197&Rendition=Web 2008; Ref Type: Electronic Citation.